Skip to Content

Λ14 (Oxybutynin Chloride Extended-Release 10 mg)

Pill with imprint Λ14 is Pink, Round and has been identified as Oxybutynin Chloride Extended-Release 10 mg. It is supplied by Advagen Pharma Limited.

Oxybutynin is used in the treatment of urinary frequency; urinary incontinence; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Λ14

Oxybutynin Chloride Extended-Release

Imprint
Λ14
Strength
10 mg
Color
Pink
Shape
Round
Availability
Rx and/or OTC
Drug Class
Urinary antispasmodics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Advagen Pharma Limited
Manufacturer
Rubicon Research Private Limited
National Drug Code (NDC)
72888-0031

Get help with Imprint Code FAQs.

Related Images for "Λ14"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.